US 12421517
Genetic modification of mammalian cells to confer resistance to CSF1R antagonists
granted A61KA61K31/4439A61K31/444
Quick answer
US patent 12421517 (Genetic modification of mammalian cells to confer resistance to CSF1R antagonists) held by The Regents of the University of California expires Mon Sep 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Sep 23 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61K, A61K31/4439, A61K31/444, A61K31/713, A61K35/30